A study published in Nature’s new open-access journal NPJ Precision Oncology reports that researchers tested the prognostic value of a clonal gene signature from malignant pleural mesothelioma tumor samples and found them to have high prognostic values and reproducibility. The results suggest that the information will help physicians treating patients with the rare form of cancer will
Dr. Sandeep J. Khandar is a cardiothoracic and thoracic surgeon at Virginia Cancer Specialists, part of the INOVA Health System in Northern Virginia. Board-certified in Cardiothoracic Thoracic and General Surgery, he has a special interest in the management of lung cancer, pleural mesothelioma, and other thoracic malignancies using minimally invasive surgical techniques. Education and Career
Dr. Miguel Alvelo-Rivera is a thoracic surgical oncologist at Henry Ford Health in Detroit, Michigan. He specializes in the use of minimally invasive surgical procedures to treat patients with lung cancer, esophageal cancer, and other thoracic malignancies, including pleural mesothelioma. Education and Career Dr. Alvelo-Rivera attended medical school and completed his initial medical residency at
Dr. John R. Roberts is a board-certified thoracic surgeon at Continuity Care, affiliated with HCA Florida JFK Hospital and HCA Florida Westside Hospital in Boca Raton, Florida. His clinical interests center on the use of minimally invasive and robotic surgical techniques for the treatment of patients diagnosed with lung cancer, esophageal cancer, and thoracic malignancies
Dr. David S. Schrump is the Surgical Chief of the Thoracic Surgery Branch of the National Cancer Institute’s Center for Cancer Research. In this role, he oversees clinical and translational research on thoracic malignancies, particularly lung cancers, esophageal cancers, and pleural mesotheliomas. Education and Career Dr. Schrump graduated from the University of Connecticut School of
Dr. Evan S. K. Ong is a general surgeon and surgical oncologist at the Swedish Medical Center in Seattle, Washington. He specializes in the use of state-of-the-art surgical techniques, including minimally invasive and robotic surgery for hepatic and pancreatic tumors, hyperthermic intraperitoneal chemoperfusion (HIPEC) for peritoneal mesothelioma, and microwave and bipolar radiofrequency ablation. Education and
Dr. Mark Richard Dylewski is a thoracic surgeon at the Baptist Health South Florida and its affiliated Miami Cancer Institute in Miami, Florida. He holds the titles of Chairman of Thoracic Surgery and Director of Robotic Thoracic Surgery at Baptist Health South Florida and Chief of Thoracic Surgery at Miami Cancer Institute. Education and Career
Dr. Gary M. Hochheiser is the Director of Thoracic Surgery and Thoracic Oncology at Maine Medical Center and the Medical Director for the facility’s Lung Screening Program. He specializes in the use of minimally invasive procedures for the treatment of pleural mesothelioma, lung cancer, and esophageal cancer, as well as benign thoracic diseases. Education and
Dr. Anthony R. Lanfranco is an interventional pulmonologist and critical care specialist at University of Colorado Medicine. He specializes in numerous procedures integral to the care of patients with pleural mesothelioma, lung cancer, and other pleural and lung diseases, including airway stenting, bronchial stenosis, bronchoscopy, cryotherapy, endoscopic lung volume reduction, and laser bronchoscopy. Education and
Dr. Pettiford is a thoracic surgeon and Section Head for Thoracic Surgery at Ochsner MD Anderson Cancer Center in New Orleans, Louisiana. He has extensive experience in the treatment of pleural mesothelioma and the use of robotic surgery for the treatment of lung cancer, benign lung disease, and esophageal cancer as well as benign lung